Evidence map›Paper›PMID 29997879›Full record

ArticleChemical science2018

Rationally designed upconversion nanoprobe for simultaneous highly sensitive ratiometric detection of fluoride ions and fluorosis theranostics.

Yuxin Liu, Anqi Jiang, Qi Jia, Xuejiao Zhai, Lidong Liu, Liyi Ma, Jing Zhou

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yuxin LiuDepartment of Chemistry , Capital Normal University , Beijing 100048 , China . Email: jingzhou@cnu.edu.cn ; Tel: +86-010-68902491.ORCID 0000-0002-2080-487X
Anqi JiangDepartment of Chemistry , Capital Normal University , Beijing 100048 , China . Email: jingzhou@cnu.edu.cn ; Tel: +86-010-68902491.
Qi JiaDepartment of Chemistry , Capital Normal University , Beijing 100048 , China . Email: jingzhou@cnu.edu.cn ; Tel: +86-010-68902491.
Xuejiao ZhaiDepartment of Chemistry , Capital Normal University , Beijing 100048 , China . Email: jingzhou@cnu.edu.cn ; Tel: +86-010-68902491.
Lidong LiuDepartment of Chemistry , Capital Normal University , Beijing 100048 , China . Email: jingzhou@cnu.edu.cn ; Tel: +86-010-68902491.
Liyi MaDepartment of Chemistry , Capital Normal University , Beijing 100048 , China . Email: jingzhou@cnu.edu.cn ; Tel: +86-010-68902491.
Jing ZhouDepartment of Chemistry , Capital Normal University , Beijing 100048 , China . Email: jingzhou@cnu.edu.cn ; Tel: +86-010-68902491.ORCID 0000-0002-5348-1966
Capital Normal University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For many years, fluorosis has been known as a worldwide disease which seriously diminishes quality of life through skeletal embrittlement and hepatic damage. Aiming to develop novel drugs for simultaneous fluorosis diagnosis and therapy, in this work we explore the feasibility of a novel pyrogallic acid-titanium(iv) complex-modified upconversion nanoprobe (UCNP-PA-Ti) for F

Identifiers

PMID29997879
PMCPMC6001250
OpenAlexW2799691631

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.